Stockscreener 앱 받기
1.60
8.05%
-0.14
시간 외 거래:
1.60
전일 마감가:
$1.74
열려 있는:
$1.73
하루 거래량:
254.55K
Relative Volume:
1.23
시가총액:
$73.37M
수익:
$134.00K
순이익/손실:
$-9.93M
주가수익비율:
-4.7059
EPS:
-0.34
순현금흐름:
$-6.72M
1주 성능:
-9.60%
1개월 성능:
-22.71%
6개월 성능:
-12.57%
1년 성능:
-34.69%
1일 변동 폭
$1.60
$1.7788
1주일 범위
$1.57
$1.81
52주 변동 폭
$1.5006
$3.22
Entera Bio Ltd Stock (ENTX) Company Profile
명칭
Entera Bio Ltd
전화
972-2-532-7151
주소
KIRYAT HADASSAH, MINRAV BUILDING, JERUSALEM
ENTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ENTX
Entera Bio Ltd
|
1.60 | 79.79M | 134.00K | -9.93M | -6.72M | -0.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Entera Bio Ltd Stock (ENTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-03-22 | 개시 | Aegis Capital | Buy |
Entera Bio Ltd 주식(ENTX)의 최신 뉴스
Will Entera Bio Ltd. stock remain a Wall Street favoriteJuly 2025 Momentum & Technical Confirmation Alerts - ulpravda.ru
Is Entera Bio Ltd. stock oversold or undervalued2025 Buyback Activity & Reliable Price Action Trade Plans - ulpravda.ru
What margin trends mean for Entera Bio Ltd. stockJuly 2025 Trends & Low Drawdown Investment Ideas - ulpravda.ru
Is Entera Bio Ltd. (5DT) stock prepared for digital transitionRate Hike & Long-Term Capital Growth Ideas - ulpravda.ru
Entera Bio Ltd.Ordinary Shares (NQ: ENTX - FinancialContent
Breakout Watch: Can Entera Bio Ltd 5DT stock surprise with quarterly results2025 Technical Overview & Low Drawdown Momentum Ideas - moha.gov.vn
[Form 4] Entera Bio Ltd. Insider Trading Activity - Stock Titan
Entera Bio Ltd. (NASDAQ: ENTX) director reports 2026 share and option grants - Stock Titan
Entera Bio (ENTX) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
Here's Why We're Not Too Worried About Entera Bio's (NASDAQ:ENTX) Cash Burn Situation - Yahoo Finance
Entera Bio (NASDAQ:ENTX) CEO Miranda Jayne Toledano Acquires 11,000 Shares - MarketBeat
Entera Bio Ltd. Stock (ENTX) Opinions on Insider Buying and Clinical Updates - Quiver Quantitative
ENTX Insider Trading - Quiver Quantitative
Aug Retail: What margin trends mean for Entera Bio Ltd stockPortfolio Performance Report & Daily Risk Controlled Trade Plans - moha.gov.vn
Entera Bio (NASDAQ:ENTX) Rating Increased to Sell at Wall Street Zen - MarketBeat
FY2025 EPS Estimates for Entera Bio Boosted by HC Wainwright - Defense World
HC Wainwright Increases Earnings Estimates for Entera Bio - MarketBeat
H.C. Wainwright reiterates Buy rating on Entera Bio stock as FDA qualifies BMD endpoint - Investing.com Australia
Entera Bio Congratulates the FNIH-ASBMR-SABRE Team on FDA’s Qualification of Total Hip BMD as Regulatory Endpoint: Huge Win for Osteoporosis Innovation - marketscreener.com
Entera Bio Announces New Data Supporting Further Development of a Proprietary First-in-Class Oral, Long-Acting PTH Tablet for Patients with Hypoparathyroidism (EB612 Program) - Sahm
FDA clears new way to test osteoporosis drugs, aiming to cut trial time - Stock Titan
Entera Bio’s oral PTH analog shows sustained calcium response By Investing.com - Investing.com Nigeria
Entera Bio’s oral PTH analog shows sustained calcium response - Investing.com
Entera Bio Ltd. Announces Promising Preclinical Data for Once-Daily Oral PTH Treatment in Hypoparathyroidism - Quiver Quantitative
New once-a-day pill aims to replace daily injections for rare calcium disorder - Stock Titan
Entera Bio Ltd. Announces New Data Supporting Further Development of A Proprietary First-In-Class Oral, Long-Acting PTH Tablet for Patients with Hypoparathyroidism (EB612 Program) - MarketScreener
Can Entera Bio Ltd. stock beat analyst upgradesJuly 2025 Earnings & Safe Investment Capital Preservation Plans - Улправда
How analysts rate Entera Bio Ltd. stock todayQuarterly Portfolio Report & Advanced Technical Analysis Signals - Улправда
Can Entera Bio Ltd. stock sustain market leadership2025 Growth vs Value & Accurate Buy Signal Notifications - Улправда
Why Entera Bio Ltd. stock appeals to analystsJuly 2025 Update & Daily Volume Surge Trade Alerts - Улправда
Can Entera Bio Ltd. stock hit analyst price targets2025 Bull vs Bear & Expert Curated Trade Setups - Улправда
How Entera Bio Ltd. stock trades before earningsWeekly Investment Summary & Smart Swing Trading Alerts - Улправда
Day Trade: Can Entera Bio Ltd. stock beat analyst upgrades2025 Key Lessons & Stepwise Trade Signal Guides - Улправда
Chart Watch: Can Entera Bio Ltd. stock sustain market leadershipIndex Update & Verified Momentum Stock Alerts - Улправда
Pharma News: Will Entera Bio Ltd stock outperform Dow Jones indexNew Guidance & Free AI Powered Buy and Sell Recommendations - moha.gov.vn
Entera Bio (NASDAQ:ENTX) Trading Down 0.9%Here's What Happened - MarketBeat
Entera Bio Ltd. (ENTX) Drops 5% in Pre-market: No Clear Catalyst - Stocks Telegraph
Is Entera Bio Ltd. (5DT) stock dividend growth reliableJuly 2025 Intraday Action & Precise Entry and Exit Recommendations - Newser
Why Entera Bio Ltd. (5DT) stock appeals to dividend investorsQuarterly Portfolio Report & Smart Swing Trading Techniques - Newser
Will Entera Bio Ltd. (5DT) stock sustain uptrend momentumStop Loss & Long-Term Safe Investment Ideas - Newser
Will Entera Bio Ltd. (5DT) stock benefit from infrastructure billMarket Activity Summary & Capital Protection Trade Alerts - Newser
Is Entera Bio Ltd. (5DT) stock good for wealth creationEarnings Trend Report & Reliable Entry Point Trade Alerts - Newser
Can Entera Bio Ltd. (5DT) stock sustain revenue momentumWeekly Market Report & Risk Controlled Daily Trade Plans - Newser
Will Entera Bio Ltd. (5DT) stock issue positive guidanceJuly 2025 Market Mood & AI Driven Stock Price Forecasts - Newser
Will Entera Bio Ltd. (5DT) stock enhance shareholder valueJuly 2025 Spike Watch & Low Risk High Win Rate Picks - Newser
How Entera Bio Ltd. (5DT) stock expands through international marketsRate Cut & Weekly Chart Analysis and Trade Guides - Newser
Will Entera Bio Ltd. (5DT) stock hit analyst forecasts2025 Market WrapUp & Expert-Curated Trade Recommendations - Newser
Entera Bio Ltd (ENTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Entera Bio Ltd 주식 (ENTX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| LIEBERMAN GERALD M | Director |
Apr 01 '25 |
Option Exercise |
1.00 |
23,952 |
23,952 |
300,160 |
0.90%
자본화:
|
볼륨(24시간):